Key Account Director, Diagnostics

Illinois, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Pharmaceuticals, DiagnosticsIndustries

Requirements

Candidates should have a minimum of 10 years of experience in Business Development and Sales within the Life Sciences sector, serving as the primary account manager. An entrepreneurial sales approach, a proactive mindset for bridging ideas to solutions, deep relationships with pharmaceutical stakeholders, and proven ability to navigate complex client organizations are essential. The role requires the ability to set aggressive yet realizable strategies and tactics, influence without authority, and demonstrate learning agility in a rapidly changing environment. Exceptional account management and articulation skills are also necessary.

Responsibilities

The Key Account Director will develop and drive global account strategy, meet and exceed revenue goals for Tempus Dx and CRO product lines, and build executive and R&D relationships. Responsibilities include becoming an expert in partner strategies to identify opportunities for the Tempus platform, negotiating and managing contracts, and aligning cross-functional teams to deliver value to clients. The role also involves partnering with clients to develop case studies, providing feedback to leadership on client responses, tracking progress against strategic objectives, and traveling approximately 30% of working time.

Skills

Account Management

Client Relationship Management

Revenue Growth

Strategic Planning

Biopharmaceutical Industry

Precision Medicine

Diagnostics

Companion Diagnostics (CDx)

Multiomics

CRO Partnerships

Drug Development

Personalized Medicine

Executive Relationship Building

R&D Relationships

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free